Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s traded shares stood at 51.29 million during the last session, with the company’s beta value hitting 1.51. At the close of trading, the stock’s price was $2.91, to imply an increase of 9.40% or $0.25 in intraday trading. The PHIO share’s 52-week high remains $10.35, putting it -255.67% down since that peak but still an impressive 47.42% since price per share fell to its 52-week low of $1.53. The company has a valuation of $5.04M, with an average of 29.84 million shares in intraday trading volume over the past 10 days and average of 5.16 million shares over the past 3 months.
Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information
After registering a 9.40% upside in the last session, Phio Pharmaceuticals Corp (PHIO) has traded red over the past five days. The 5-day price performance for the stock is 72.19%, and 3.56% over 30 days. With these gigs, the year-to-date price performance is 61.67%. Short interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) saw shorts transact 51491.0 shares and set a 0.5 days time to cover.
PHIO Dividends
Phio Pharmaceuticals Corp has its next earnings report out in February. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders
Phio Pharmaceuticals Corp insiders hold 4.81% of total outstanding shares, with institutional holders owning 3.02% of the shares at 3.17% float percentage. In total, 3.02% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Phio Pharmaceuticals Corp (PHIO) shares. Going by data provided on Nov 30, 2024 , Fidelity Extended Market Index Fund holds roughly 4.29 shares. This is just over 0.29% of the total shares, with a market valuation of $12483.0. Data from the same date shows that the other fund manager holds a little less at 2.71, or 0.18% of the shares, all valued at about 7877.0.
